Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ClosetInvestor's Profile
Displaying 1-50 of 1914 result(s).
CYDY CytoDyn Inc
07/09/2021 10:03:41 PM
“Who was responsible for due dili (5)
CYDY CytoDyn Inc
07/09/2021 9:36:28 PM
“Caracciolo was Executive Chairma (5)
CYDY CytoDyn Inc
05/27/2021 2:21:09 PM
“Things that make you go hmmm. I (6)
CYDY CytoDyn Inc
05/26/2021 11:51:04 PM
“Maybe Mr. Rosenbaum is ClosetInv (10)
CYDY CytoDyn Inc
05/19/2021 4:27:41 PM
“In my opinion, Dr. J missed the (3)
CYDY CytoDyn Inc
05/09/2021 9:20:04 PM
“EUA? I wasn't able to catch the (2)
CYDY CytoDyn Inc
05/05/2021 9:08:14 AM
“JLang - this is why you're no lo (5)
CYDY CytoDyn Inc
04/29/2021 6:03:32 PM
“Still waiting for you to show us (3)
CYDY CytoDyn Inc
04/29/2021 3:32:20 PM
“closetinvestor, Sorry to say thi (1)
CYDY CytoDyn Inc
04/29/2021 3:30:11 PM
“Will you promise to one day tell (2)
CYDY CytoDyn Inc
04/29/2021 3:07:31 PM
“I have been invested in this com (2)
CYDY CytoDyn Inc
04/29/2021 3:03:50 PM
“So why are you advocating for a (5)
CYDY CytoDyn Inc
04/29/2021 2:27:15 PM
“Allow me to shock the world by a (5)
CYDY CytoDyn Inc
04/29/2021 2:21:07 PM
“This is why the folks calling fo (4)
CYDY CytoDyn Inc
04/29/2021 10:07:21 AM
“Relax.. I'm not letting the cat (8)
CYDY CytoDyn Inc
04/29/2021 9:53:09 AM
“I say, so what, it's financing o (5)
CYDY CytoDyn Inc
04/29/2021 9:38:24 AM
“Nah, penny stock players wouldn' (4)
CYDY CytoDyn Inc
04/29/2021 9:28:17 AM
“There's bigger 'booms' lurking o (4)
CYDY CytoDyn Inc
04/28/2021 10:30:10 PM
“19 million shares is less than 3 (6)
CYDY CytoDyn Inc
04/28/2021 10:28:05 PM
“Still waiting for you to show us (3)
CYDY CytoDyn Inc
04/28/2021 10:26:19 PM
“When SP is $10+ 28 million 2.8 m (3)
CYDY CytoDyn Inc
04/28/2021 10:24:42 PM
“Please show me where all these s (4)
CYDY CytoDyn Inc
04/28/2021 8:08:32 PM
“You don’t share the same opini (3)
CYDY CytoDyn Inc
04/28/2021 5:12:09 PM
“April 3rd 2020 PR - CytoDyn File (1)
CYDY CytoDyn Inc
04/28/2021 5:03:25 PM
“But that's no excuse for advanci (2)
CYDY CytoDyn Inc
04/27/2021 10:10:07 PM
“Yet you have dedicated your life (3)
CYDY CytoDyn Inc
04/27/2021 9:46:21 PM
“Then you owe Nader an apology.â€
CYDY CytoDyn Inc
04/27/2021 8:25:16 PM
“So you are posting speculation a (3)
CYDY CytoDyn Inc
04/27/2021 8:17:46 PM
“THE FDA said 2 DOSES nothing mor (2)
CYDY CytoDyn Inc
04/27/2021 7:20:16 PM
“If you disagree and think the FD (10)
CYDY CytoDyn Inc
04/27/2021 5:06:20 PM
“How do you want Nader to behave (2)
CYDY CytoDyn Inc
04/27/2021 5:04:31 PM
Dr. Bream is live now. https://www. (3)
CYDY CytoDyn Inc
04/26/2021 10:50:08 PM
Reminder for Dr. Bream’s live str (4)
CYDY CytoDyn Inc
04/26/2021 8:29:08 PM
“HIPAA agreement is a regulatory (2)
CYDY CytoDyn Inc
04/26/2021 2:14:58 PM
“disagree, it's PR, not science. (9)
CYDY CytoDyn Inc
04/25/2021 3:58:31 PM
“i guess maybe the second $25 mil (3)
CYDY CytoDyn Inc
04/25/2021 1:52:07 PM
Given the recent talk about leronli (6)
CYDY CytoDyn Inc
04/24/2021 11:12:52 AM
“I would guess that who deleted w (3)
CYDY CytoDyn Inc
04/24/2021 11:06:27 AM
“And the SP should be jumping UP. (6)
CYDY CytoDyn Inc
04/24/2021 9:34:47 AM
“Anyone who thinks this isn’t t (5)
CYDY CytoDyn Inc
04/24/2021 9:17:48 AM
“He's clearly NOT referring to Fi (4)
CYDY CytoDyn Inc
04/24/2021 1:55:18 AM
Dr. Bream is talking therapeutics ( (6)
CYDY CytoDyn Inc
04/23/2021 11:27:07 PM
“I should delete that because you (2)
CYDY CytoDyn Inc
04/23/2021 9:13:24 PM
“If the US doesn't want to be a c (9)
CYDY CytoDyn Inc
04/23/2021 8:06:54 PM
“I could be wrong but in today's (3)
CYDY CytoDyn Inc
04/23/2021 7:30:28 PM
“Also seems that the new investor (1)
CYDY CytoDyn Inc
04/23/2021 6:08:19 PM
“The FDA Director General Eric Do (1)
CYDY CytoDyn Inc
04/23/2021 6:02:44 PM
“Mahoob didnt hit his objectives (2)
CYDY CytoDyn Inc
04/20/2021 3:25:19 PM
“Is anyone else mystified about C (5)
CYDY CytoDyn Inc
04/18/2021 10:38:45 PM
“I think we are in the gray zone (4)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • JDE Peet's Accelerates Share Buyback to Boost Value
  • XWELL, Inc. Celebrates Compliance with Nasdaq Standards
  • Schouw & Co.'s Share Buy-Back Updates Through August 2025
  • PodcastOne Reports Q1 Financial Results and Investor Webcast
  • Safran DSI Powers AstroForge's Asteroid Mining Mission
  • LiveOne to Reveal Q1 Fiscal 2026 Results and Webcast Info
  • WTW Hires Nicholas Carbo as Senior Director for ICT Services
  • U Power and UNEX EV Partner with Didi to Revolutionize EVs
  • Gabelli Funds Prepares for Aerospace & Defense Symposium 2025
  • Paramount and TKO Strike Historic Deal for UFC Broadcast Rights
  • 4DMT Sees Promising Growth and Milestones in Q2 2025
  • Cache Public Schools Launches Eco-Friendly Electric Buses
  • Helius Minerals Advances Serra Pelada Gold-PGM Project Progress
  • vTv Therapeutics Secures Patent for Cadisegliatin Advancements
  • Theriva Biologics: Q2 Results and Future Milestones for Cancer Therapies
  • Analysts Weigh In: Investment Opportunities and Stock Ratings
  • C3.ai's Recent Downshift: Analysts Adjust Price Targets
  • Health Care Stocks to Watch: Big Upside Potential This Month
  • Top Wall Street Analyst Stock Recommendations This Week
  • Lincoln Educational Services Boosts Revenue and Student Growth
  • Blue Gold's Strategic Acquisition: A Smart Move for Investors
  • Upexi, Inc. Shareholder Investigation Highlights Board Duties
  • Evaxion Preparing for Exciting Business Update on Upcoming Results
  • 180 Life Sciences Raises $156 Million in Convertible Notes Sale
  • OverActive Media Plans Upcoming Earnings Call for Q2 2025
  • Qubitera Holdings Unveils Ambitious Global Health Tech Plans
  • Ben Hays Takes Over as Director of YPTC's Phoenix Office
  • Jack Henry Enhances Digital Banking Experience with New Tools
  • Catheter Precision's Impressive Q2 Growth and Innovations
  • Trump Media Enhances Bitcoin ETF Initiative for Future Growth
  • Innovative AI Enhances Recruiting with Immersive Job Previews
  • CervoMed's Progress in Clinical Trials and Financial Insights
  • Hyperlink InfoSystem Set to Showcase Innovations at GITEX 2025
  • Fundamental Global Inc. Transitions to New Ticker Symbols
  • Protara Therapeutics Reports Strong Financial Results for Q2 2025
  • ScaleFlux Driving the Future of Storage Innovation
  • NRx Pharmaceuticals Advances Mental Health with FDA Designation
  • ArriVent BioPharma Skirts Losses with Innovative Drug Pipeline
  • Dynacor Group Inc. Reveals Strong Q2-2025 Financial Growth
  • Investigation Initiated Following Connex Credit Union Breach
  • Easterly ROCMuni Fund Shareholders Urged to Act Before Deadline
  • Exciting Developments from 4D Molecular Therapeutics in Q2 2025
  • Barrett-Jackson Data Breach: Eye-Opening Customer Risks
  • Lincoln Educational Services Reports Strong Q2 Growth in 2025
  • Key Earnings Reports This Week: Archer, Rigetti, Oklo & Others
  • Understanding the RxSight, Inc. Lawsuit: A Shareholder's Guide
  • Replimune Group Investors Urged to Join Class Action Now
  • Long-Term Impact of INO-3107 on Surgery for RRP Patients
  • Experience Luxury Living: Mattamy Homes Unveils Prescott Model
  • Chipotle IQ Contest Revamped with Exciting Rewards Ahead
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site